Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of Denmark’s economic growth.
Tag: Diabetes
-
The N.Y.C. Neighborhood That’s Getting Even Thinner on Ozempic
Prescriptions for a new class of medications used for diabetes and weight loss are concentrated in the city’s wealthier, whiter and healthier neighborhoods.
-
Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
-
Where Ozempic, Wegovy and New Weight Loss Drugs Came From
The empty auditoriums, Gila monsters, resistant pharmaceutical executives and enigmas that led to Ozempic and other drugs that may change how society thinks about obesity.
-
To Fix Health Care, We Need to Look Beyond Medicine
We can start by expanding access to care, but we also need to look beyond medicine and address harmful behaviors and poverty.